Stock AnalizCabot Corp. CBT
Major Chemicals · data as of November 13, 2026
Cabot Corp. (CBT) is a industrial company listed in the US with a market value of about $3.7B. In the twelve months to September 30, 2026 it had revenue of $3.7B and net income of $213M, a net margin of 5.7%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is shareholder returns (4/5); the weakest is future growth (0/5).
Key numbers: a P/E of 17.9, a price to free cash flow of 17.4, 5-year revenue growth of 7% a year, a 5-year average ROIC of 16%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 5% below the current price.
Score: 2.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
- Interest covered more than 5 times
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.7B | $4.0B | $3.9B | $4.3B | $3.4B | $2.6B | $3.3B | $3.2B | $2.7B | $2.4B |
| Net income | $213M | $331M | $380M | $445M | $209M | $250M | -$238M | $157M | -$113M | $248M | $147M |
| Free cash flow | $214M | $391M | $451M | $351M | -$111M | $62M | $177M | $139M | $69M | $201M | $280M |
| EPS (diluted) | $4.01 | $6.02 | $6.72 | $7.73 | $3.62 | $4.34 | $-4.21 | $2.63 | $-1.85 | $3.91 | $2.32 |
| Net margin | 5.7% | 8.9% | 9.5% | 11.3% | 4.8% | 7.3% | -9.1% | 4.7% | -3.5% | 9.1% | 6.1% |
| ROIC | — | 14.7% | 18.5% | 16.9% | 12.9% | 14.8% | 0.9% | 10.4% | 6.0% | 12.4% | 9.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 6 analysts is $85.33, 19% above the current price; targets range from $68.00 to $95.00; the consensus rating is “Buy”; expected EPS is $6.56 for the fiscal year ending September 30, 2027.
Frequently asked questions
What is Cabot’s P/E ratio?
About 17.9, based on the last twelve months of diluted earnings per share (forward P/E about 10.7).
Is Cabot stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 5% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Cabot pay a dividend?
Yes. The dividend yield is about 2.55%, and it has paid dividends for 10 years in our data.
Is Cabot a good stock to buy?
We do not give buy or sell advice. Cabot scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.